Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis

FEMS Immunology and Medical Microbiology

Volumn 21, Issue 2, 1998, Pages 149-157

  Rastogi, Nalin ^a   Goh, Khye Seng ^a   Horgen, Lionel ^a   Barrow, William W ^a,b  

^a Institut Pasteur de Guadeloupe   (Guadeloupe)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

Antituberculous drug; Cerulenin; Drug synergy; Ethambutol; Mycobacterium tuberculosis; Trans Cinnamic acid

Indexed keywords

AMIKACIN; CERULENIN; CINNAMIC ACID; CLOFAZIMINE; ETHAMBUTOL; ISONIAZID; OFLOXACIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ARTICLE; BACTERIAL COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; CERULENIN; CINNAMATES; COLONY COUNT, MICROBIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ETHAMBUTOL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0344813713     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(98)00044-3     Document Type: Article

References (39)

1. Bloch, A.B., Cauthen, G.M., Onorato, I.M., Kenneth, G., Dansbury, G., Kelly, G.D., Driver, C.R. and Snider, D.E. (1994) Nationwide survey of drug-resistant tuberculosis in the United States. J. Am. Med. Assoc. 271, 665-671.
2. Rastogi, N., Kochi, A., Vareldzis, B., Styblo, K., Crawford, J.T., Jarvis, W.R., McGowan, J.E., Jr., Perrone, C., David, H.L., Zhang, Y., Cohn, D.L. and Iseman, M.D. (1993) 9th Forum in Microbiology, 'Emergence of multiple-drug-resistant tuberculosis: fundamental and applied research aspects, global issues and current strategies'. Res. Microbiol. 144, 103-158.
3. Rastogi, N., Ross, B.C., Dwyer, B., Goh, K.S., Clavel-Sérès, S., Jeantils, V. and Cruaud, P. (1993) Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis. Eur. J. Clin. Microbiol. Infect. Dis. 11, 901-907.
4. Frieden, T.R., Sterling, T., Pablos-Mendez, A., Kilburn, J.O., Gauthen, G.M. and Dooley, S.W. (1993) The emergence of drug-resistant tuberculosis in New York City. New Engl. J. Med. 328, 521-526.
5. Salomon, N., Perlman, D.C., Friedmann, P., Buchstein, S., Kreiswirth, B.K. and Mildvan, D. (1995) Predictors and outcome of multidrug resistant tuberculosis. Clin. Infect. Dis. 21, 1245-1252.
6. Turett, G.S., Telzak, E.E., Torian, L.V., Blum S., Alland, D., Weisfuse, I. and Fazal, B.A. (1995) Improved outcomes for patients with multidrug-resistant tuberculosis. Clin. Infect. Dis. 21, 1238-1244.
7. Iseman, M.D. (1993) Treatment of multidrug-resistant tuberculosis. New Engl. J. Med. 329, 784-791.
8. Cavalieri, S.J., Biehle, J.R. and Sanders, W.E., Jr. (1995) Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 39, 1542-1545.
9. Jagannath, C., Reddy, V.M. and Gangadharam, P.R.J. (1995) Enhancement of drug susceptibility of multidrug resistant strains of Mycobacterium tuberculosis by ethambutol and dimethyl sulphoxide. J. Antimicrob. Chemother. 35, 381-390.
10. Rastogi, N. (1993) Mycobacteria as intracellular pathogens: current notions of pathogenicity, virulence, and drug resistance and their relation to effective therapy. In: Antimicrobial Agents and Intracellular Pathogens (Raoult, D., Ed.), pp. 245-300. CRC Press, Boca Raton, FL.
11. Rastogi, N., Fréhel, C., Ryter, A., Ohayon, O., Lesourd, M. and David, H.L. (1981) Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for the exclusion of antimicrobial agents? Antimicrob. Agents Chemother. 20, 666-677.
12. Barrow, W.W., Wright, E.L., Goh, K.S. and Rastogi, N. (1993) Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium. Antimicrob. Agents Chemother. 37, 652-661.
13. Rastogi, N. and Goh, K.S. (1990) Action of 1-isonicotinyl-2-palmitoyl hydrazine against the Mycobacterium avium complex and enhancement of its activity by m-fluorophenylalanine. Antimicrob. Agents Chemother. 34, 2061-2064.
14. Rastogi, N., Goh, K.S., Wright, E.L. and Barrow, W.W. (1994) Potential drug targets for Mycobacterium avium defined by using radiometric drug-inhibitor combination techniques. Antimicrob. Agents Chemother. 38, 2287-2295.
15. Rastogi, N. and Labrousse, V. (1991) Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex. Antimicrob. Agents Chemother. 35, 462-470.
16. Nomura, S., Horiuchi, T., Omura, S. and Hata, T. (1972) The action mechanism of cerulenin. J. Biochem. (Tokyo) 71, 783-786.
17. Omura, S. (1976) The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. Bacteriol. Rev. 40, 681-697.
18. Takayama, K., Armstrong, E.L., Kunugi, K.A., and Kilburn, J.O. (1979) Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis. Antimicrob. Agents Chemother. 16, 240-242.
19. Takayama, K. and Kilburn, J.O. (1989) Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 33, 1493-1499.
20. Lee, C.N. and Heifets, L.B. (1987) Determination of minimal inhibitory concentrations of antituberculous drugs by radiometric and conventional methods. Am. Rev. Respir. Dis. 136, 349-352.
21. Rastogi, N., Goh, K.S., Bryskier, A. and Devallois, A. (1996) In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 40, 1610-1616.
22. Siddiqi, S.H., Hawkins, J.E. and Laszlo, A. (1985) Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J. Clin. Microbiol. 22, 919-923.
23. Hoffner, S.E., Källenius, G., Beezer, A.E. and Svenson, S.B. (1989) Studies on the mechanisms of synergistic effects of ethambutol and other antibacterial drugs on Mycobacterium avium complex. Acta Leprol. (Geneva) 7 (Suppl. 1), 195-199.
24. Hoffner, S.E., Svenson, S.B. and Källenius, G. (1990) Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium. Eur. J. Clin. Microbiol. 6, 530-535.
25. Rastogi, N., Goh, K.S. and Clavel-Sérès, S. (1997) Stazyme, a mycobacteriolytic preparation from a Staphylococcus strain, is able to break the permeability barrier in multiple drug resistant Mycobacterium avium. FEMS Immunol. Med. Microbiol. 19, 297-305.
26. Mahajan, S. and Khuller, G.K. (1984) Cerulenin effect on phospholipid metabolism in Mycobacterium smegmatis ATCC 607. Biochim. Biophys. Acta 795, 493-498.
27. Mahajan, S. and Khuller, G.K. (1985) Cerulenin inhibition of lipid synthesis and its reversal by exogenous fatty acids in Mycobacterium smegmatis ATCC 607. Can. J. Biochem. Cell. Biol. 63, 85-90.
28. Harris, E.B., Franzblau, S.G. and Hastings, R.C. (1988) Inhibition of phenolic glycolipid-I synthesis in extracellular Mycobacterium leprae as an indicator of antimicrobial activity. Int. J. Lepr. 56, 588-591.
29. Rastogi, N., Hellio, R. and David, H.L. (1991) A new insight into the mycobacterial cell envelope architecture by the localization of antigens in ultrathin sections. Zbl. Bakt. 275, 287-302.
30. Rodinov, D.G. and Ishiguro E.E. (1996) Dependence of peptidoglycan metabolism on phospholipid synthesis during growth of Escherichia coli. Microbiology 142, 2871-2877.
31. Rastogi, N. (1991) Recent observations concerning structure and function relationships in the mycobacterial cell envelope: elaboration of a model in terms of mycobacterial pathogenicity, virulence and drug resistance. Res. Microbiol. 142, 464-476.
32. Daneo-Moore, L., Boubeau, P., Weinstein, R. and Carson, D. (1979) Effects of cerulenin on antibiotic-induced lysis of Streptococcus faecalis (S. Faecium) Antimicrob. Agents Chemother. 16, 858-861.
33. Ramanan, P.N. and Rao, M.N. (1987) Antimicrobial activity of cinnamic acid derivatives. Indian J. Exp. Biol. 25, 42-43.
34. Rastogi, N. and David, H.L. (1988) Mechanisms of pathogenicity in mycobacteria. Biochimie (Paris) 70, 1101-1120.
35. Sutherland, J.B., Crawford, D.L. and Pometto, A.L. (1983) Metabolism of cinnamic, p-coumaric, and ferulic acids by Streptomyces setonii. Can. J. Microbiol. 29, 1253-1257.
36. Ramos-Nino, M.E., Clifford, M.N. and Adams, M.R. (1996) Quantitative structure activity relationship for the effect of benzoic acids, cinnamic acids, and benzaldehydes on Listeria monocytogenes. J. Appl. Bacteriol. 80, 303-310.
37. Curtis, N.A., Eisenstadt, R.L., East S.J., Cornford, R.J., Walker, L.A. and White A.J. (1988) Iron-regulated outer membrane proteins of Escherichia coli K-12 and mechanism of action of catechol-substituted cephalosporins. Antimicrob. Agents Chemother. 32, 1879-1886.
38. Bergeron, R.J., Elliott, G.T., Kline S.J., Ramphal, R. and St. James, L. (1983) Bacteriostatic and fungostatic action of catecholamide iron chelators. Antimicrob. Agents Chemother. 24, 725-730.
39. Ryan, F. (1992) The Forgotten Plague. Little, Brown and Company, Boston, MA.